- Section 1 Patients and their treatment
- Section 2 Background to medicine
- Section 3 Cell biology
- Section 4 Immunological mechanisms
- Section 5 Principles of clinical oncology
- Section 6 Old age medicine
- Section 7 Pain and palliative care
- Section 8 Infectious diseases
- Section 9 Sexually transmitted diseases
- Section 10 Environmental medicine, occupational medicine, and poisoning
- Section 11 Nutrition
- Section 12 Metabolic disorders
- Section 13 Endocrine disorders
- Section 14 Medical disorders in pregnancy
- Section 15 Gastroenterological disorders
- Section 16 Cardiovascular disorders
- Section 17 Critical care medicine
- Section 18 Respiratory disorders
- Section 19 Rheumatological disorders
- Section 20 Disorders of the skeleton
- Section 21 Disorders of the kidney and urinary tract
- Section 22 Haematological disorders
- 22.1 Introduction to haematology
- 22.2 Haematopoiesis
- 22.3 Myeloid disease
- 22.3.1 Granulocytes in health and disease
- 22.3.2 Myelodysplastic syndromes
- 22.3.3 Acute myeloid leukaemia
- 22.3.4 Chronic myeloid leukaemia
- 22.3.5 The polycythaemias
- 22.3.6 Thrombocytosis and essential thrombocythaemia
- 22.3.7 Primary myelofibrosis
- 22.3.8 Eosinophilia
- 22.3.9 Histiocytosis
- 22.4 Lymphoid disease
- 22.5 Bone marrow failure
- 22.6 Erythroid disorders
- 22.7 Haemostasis
- 22.8 Transfusion and transplantation
- Section 23 Disorders of the skin
- Section 24 Neurological disorders
- Section 25 Disorders of the eye
- Section 26 Psychiatric and drug-related disorders
- Section 27 Forensic medicine
- Section 28 Sport and exercise medicine
- Section 29 Biochemistry in medicine
- Section 30 Acute medicine
Granulocytes in health and disease
- Chapter:
- Granulocytes in health and disease
- Author(s):
Joseph Sinning
, and Nancy Berliner
- DOI:
- 10.1093/med/9780198746690.003.0513
White cells (leucocytes) mediate inflammatory and immune responses and are key to the defence of the host against microbial pathogens. Subpopulations of leucocytes include granulocytes—neutrophils, eosinophils, and basophils; monocytes; and lymphocytes. Neutrophils comprise half the peripheral circulating leucocytes and are characterized by heterogeneous primary and secondary granules and a segmented nucleus. Maturation from the haematopoietic stem cell occurs in the bone marrow and takes 10 to 14 days. Neutrophilia—defined as an increase in the circulating neutrophil count to greater than 7.5 × 106/µl, usually occurs as an acquired reactive response to underlying disease. Causes include infection, particularly bacterial; drugs; malignancies, and hereditary conditions. Neutropenia—defined as a reduction in the absolute neutrophil count to less than 1.5 × 106/µl, is of particular importance because, when severe (<0.5 × 106/µl), it markedly increases the risk of life-threatening infection. Causes include drugs and toxins, postinfectious, nutritional deficiencies, autoimmune, large granular lymphocytosis, and congenital. Disorders of neutrophil function include chronic granulomatous disease, leucocyte adhesion deficiency, myeloperoxidase deficiency, and Chediak–Higashi syndrome. Monocytes share a common myeloid precursor with granulocytes, present antigens to T cells, produce several important cytokines with immunomodulatory and inflammatory functions, and are the precursors to resident tissue macrophages. They are especially important in defence against intracellular pathogens. Causes of monocytosis (>0.9 × 106/µl) include chronic infection, autoimmune diseases, and malignancy. Basophils are nonphagocytic granulocytes that function in immediate-type hypersensitivity. Basophilia (> 0.2 × 106/µl) is seen in myeloproliferative disorders, hypersensitivity reactions, and with some viral infections.
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
- Section 1 Patients and their treatment
- Section 2 Background to medicine
- Section 3 Cell biology
- Section 4 Immunological mechanisms
- Section 5 Principles of clinical oncology
- Section 6 Old age medicine
- Section 7 Pain and palliative care
- Section 8 Infectious diseases
- Section 9 Sexually transmitted diseases
- Section 10 Environmental medicine, occupational medicine, and poisoning
- Section 11 Nutrition
- Section 12 Metabolic disorders
- Section 13 Endocrine disorders
- Section 14 Medical disorders in pregnancy
- Section 15 Gastroenterological disorders
- Section 16 Cardiovascular disorders
- Section 17 Critical care medicine
- Section 18 Respiratory disorders
- Section 19 Rheumatological disorders
- Section 20 Disorders of the skeleton
- Section 21 Disorders of the kidney and urinary tract
- Section 22 Haematological disorders
- 22.1 Introduction to haematology
- 22.2 Haematopoiesis
- 22.3 Myeloid disease
- 22.3.1 Granulocytes in health and disease
- 22.3.2 Myelodysplastic syndromes
- 22.3.3 Acute myeloid leukaemia
- 22.3.4 Chronic myeloid leukaemia
- 22.3.5 The polycythaemias
- 22.3.6 Thrombocytosis and essential thrombocythaemia
- 22.3.7 Primary myelofibrosis
- 22.3.8 Eosinophilia
- 22.3.9 Histiocytosis
- 22.4 Lymphoid disease
- 22.5 Bone marrow failure
- 22.6 Erythroid disorders
- 22.7 Haemostasis
- 22.8 Transfusion and transplantation
- Section 23 Disorders of the skin
- Section 24 Neurological disorders
- Section 25 Disorders of the eye
- Section 26 Psychiatric and drug-related disorders
- Section 27 Forensic medicine
- Section 28 Sport and exercise medicine
- Section 29 Biochemistry in medicine
- Section 30 Acute medicine